The Patent Finder

Immusant, Inc.

Also on record
Records under this name other than patents Immusant, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Immusant, Inc.

PatentTitleStatus Expires Confidence
US 8,835,603Agents for the Treatment of Celiac Disease
Lapsed on the fee record
Ended Sep 16, 2026 · High confidence
Lapsed on the fee recordEnded Sep 16, 2026High confidence
US 9,464,120Compositions for Treatment of Celiac Disease
Lapsed on the fee record
Ended Oct 11, 2024 · Medium confidence
Lapsed on the fee recordEnded Oct 11, 2024Medium confidence
US 10,473,647Peptides for use in treatment and diagnosis of type 1 diabetes
Lapsed on the fee record
Ended Nov 12, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 12, 2023From the USPTO record
US 10,449,228Dosage of a gluten peptide composition
Lapsed on the fee record
Ended Oct 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 22, 2023From the USPTO record
US 10,370,718Use of HLA genetic status to assess or select treatment of celiac disease
Lapsed on the fee record
Ended Aug 6, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 6, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited